Cardiac Tissue Engineering Market Report 2026

Cardiac Tissue Engineering Market Overview

• Cardiac Tissue Engineering market size has reached to $0.8 billion in 2025 • Expected to grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 19% • Growth Driver: Rising Cardiovascular Disease Rates Boost The Market Growth • North America was the largest region in 2025.

What Is Covered Under Cardiac Tissue Engineering Market?

Cardiac tissue engineering refers to the use of advanced biomedical techniques to develop functional heart tissue that can repair or regenerate damaged heart muscles. It involves combining cells, biomaterials, and bioactive factors to create engineered tissues that can restore cardiac function or aid in heart disease treatment. The main products in cardiac tissue engineering are heart valves and vascular grafts. Heart valves are structures that regulate blood flow within the heart, ensuring it moves in the correct direction. The different materials are stem cells and scaffolds. The various applications are myocardial infarction, heart valve repair or replacement, congenital heart disease treatment, and others, and are used by end users such as hospitals and clinics, academic and research institutes, and other end users.

What Is The Cardiac Tissue Engineering Market Growth Forecast?

The cardiac tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to increasing investment in regenerative medicine, rising demand for alternatives to donor tissues, expansion of personalized cardiac therapies, growing clinical translation of engineered tissues, advancements in biofabrication techniques. Major trends in the forecast period include increasing development of tissue-engineered heart valves, rising use of stem cell-based cardiac therapies, growing adoption of advanced biomaterial scaffolds, expansion of regenerative approaches for myocardial repair, enhanced focus on functional tissue maturation.

Global Cardiac Tissue Engineering Market Segmentation

1) By Product: Heart Valves, Vascular Grafts 2) By Material: Stem Cells, Scaffolds 3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications 4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users Subsegments: 1) By Heart Valves: Bioprosthetic Heart Valves, Tissue-Engineered Heart Valves 2) By Vascular Grafts: Biologic Vascular Grafts, Tissue-Engineered Vascular Grafts

What Are The Drivers Of The Cardiac Tissue Engineering Market?

The rising incidence of cardiovascular diseases is expected to propel the growth of the cardiac tissue engineering market going forward. Cardiac tissue engineering is the interdisciplinary field focused on creating biological or bioartificial constructs to repair, regenerate, or replace damaged heart tissue. The rising incidence of cardiovascular diseases is primarily driven by unhealthy lifestyle choices, including poor diet, physical inactivity, smoking, and increasing rates of obesity and diabetes. Cardiac tissue engineering is used in cardiovascular diseases by developing biomaterials, cell-based therapies, and bioengineered tissues to repair or regenerate damaged heart muscle and restore cardiac function. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based governmental organization, the percentage of coronary heart disease in female adults aged 18 and over slightly increased to 3.7% in 2023 from 3.6% in 2022. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the cardiac tissue engineering industry. The rising healthcare expenditure is expected to propel the growth of the cardiac tissue engineering market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Higher healthcare expenditure drives cardiac tissue engineering by funding research, clinical trials, infrastructure, and adoption of regenerative heart therapies. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the cardiac tissue engineering industry.

Key Players In The Global Cardiac Tissue Engineering Market

Major companies operating in the cardiac tissue engineering market are Xeltis AG, Humacyte Inc., Carmat S.A., Artivion Inc., Tissue Regenix Group plc, Cytograft Tissue Engineering Inc., BioCardia Inc., Bioheart Inc., Cardio3 Biosciences, Osiris Therapeutics Inc., StemCells Inc., CorMatrix Cardiovascular Inc., Vascugen Inc., CellProthera S.A., Myocardial Solutions Inc., Vericel Corporation, Lineage Cell Therapeutics Inc., Pluristem Therapeutics Inc., Reva Medical Inc., SynCardia Systems Inc.

What Are Latest Mergers And Acquisitions In The Cardiac Tissue Engineering Market?

In April 2024, Valo Health LLC, a US-based technology company, acquired TARA Biosystems Inc. for an undisclosed amount. With this acquisition, Valo Health uses TARA's proprietary human cardiac disease platform to advance the discovery of new medicines for cardiovascular diseases. TARA Biosystems Inc. is a US-based company developing 3D-engineered cardiac tissue models for drug discovery and disease modeling.

Regional Outlook

North America was the largest region in the cardiac tissue engineering market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiac Tissue Engineering Market?

The cardiac tissue engineering market consists of revenues earned by entities by providing services such as the development of stem cell therapy and regeneration services, tissue engineering consultation and research services, and bioreactor and biomanufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac tissue engineering market includes sales of bioengineered cardiac tissues, biomaterials, cardiac tissue constructs, tissue scaffolds, bioactive molecules, and bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiac Tissue Engineering Market Report 2026?

The cardiac tissue engineering market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac tissue engineering industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.